Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward

Clin Gastroenterol Hepatol. 2022 Feb;20(2):e342. doi: 10.1016/j.cgh.2021.03.014. Epub 2021 Mar 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / epidemiology
  • Guanine / analogs & derivatives
  • Guanine / therapeutic use
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / epidemiology
  • Tenofovir / therapeutic use

Substances

  • Antiviral Agents
  • entecavir
  • Guanine
  • Tenofovir